Balancing the risks and benefits of long-term antiplatelet therapies for cardiovascular disease: clinical, research, and regulatory implications

J Am Heart Assoc. 2015 Mar 19;4(3):e001897. doi: 10.1161/JAHA.115.001897.
No abstract available

Keywords: Editorials; arteriosclerosis; platelets; prevention; thrombin.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Drug Approval*
  • Female
  • Humans
  • Lactones / therapeutic use*
  • Male
  • Myocardial Infarction / drug therapy*
  • Peripheral Arterial Disease / drug therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Pyridines / therapeutic use*
  • Receptor, PAR-1 / antagonists & inhibitors*
  • Secondary Prevention / methods*

Substances

  • Lactones
  • Platelet Aggregation Inhibitors
  • Pyridines
  • Receptor, PAR-1